Clinical outcomes with BG-12 treatment in CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis), a multicentre, randomised, placebo-controlled, phase 3 study

被引：0
|
作者：
Havrdova, E.
Fox, R. J.
Miller, D.
Phillips, J. T.
Kita, M.
Hutchinson, M.
Yang, M.
Zhang, R.
Novas, M.
Viglietta, V.
Dawson, K. T.
机构：
[1] Charles Univ Prague, Prague, Czech Republic
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] UCL, Inst Neurol, London, England
[4] Baylor Inst Immunol Res, Dallas, TX USA
[5] Virginia Mason Med Ctr, Seattle, WA 98101 USA
[6] St Vincents Univ Hosp, Dublin 4, Ireland
[7] Biogen Idec Inc, Cambridge, MD USA
来源：
JOURNAL OF NEUROLOGY | 2012年 / 259卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [1] Clinical and neuroimaging outcomes with BG-12 treatment in CONFIRM (comparator and an oral fumarate in relapsing-remitting multiple sclerosis), a multicenter, randomized, placebo-controlled, phase-3 study
    Havrdova, E.
    Miller, D.
    Fox, R. J.
    Phillips, J. T.
    Kita, M.
    Hutchinson, M.
    MacManus, D.
    Yousry, T.
    Yang, M.
    Zhang, R.
    Novas, M.
    Viglietta, V.
    Dawson, K. T.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 87 - 87
  • [2] Effects of BG-12 on magnetic resonance imaging outcomes in CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis), a randomized, placebo-controlled, phase 3 study
    Miller, D.
    Fox, R. J.
    Phillips, J. T.
    Kita, M.
    Hutchinson, M.
    Havrdova, E.
    MacManus, D.
    Yousry, T.
    Zhang, R.
    Viglietta, V.
    Dawson, K. T.
    [J]. JOURNAL OF NEUROLOGY, 2012, 259 : S36 - S37
  • [3] Safety and tolerability of BG-12 in patients with relapsing-remitting multiple sclerosis: results from the phase 3 CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study
    Havrdova, E.
    Phillips, J. T.
    Fox, R. J.
    Miller, D.
    Kita, M.
    Hutchinson, M.
    Raghupathi, K.
    Yuan, H.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Dawson, K. T.
    [J]. JOURNAL OF NEUROLOGY, 2012, 259 : S105 - S105
  • [4] Effect of BG-12 in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study
    Hutchinson, M.
    Fox, R. J.
    Miller, D.
    Phillips, J. T.
    Kita, M.
    Havrdova, E.
    Yang, M.
    Zhang, R.
    Novas, M.
    Viglietta, V.
    Dawson, K. T.
    [J]. JOURNAL OF NEUROLOGY, 2012, 259 : S105 - S106
  • [5] Effect of BG-12 in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM (comparator and an oral fumarate in relapsing-remitting multiple sclerosis) study
    Hutchinson, M.
    Fox, R. J.
    Miller, D.
    Phillips, J. T.
    Kita, M.
    Havrdova, E.
    O'Gorman, J.
    Yang, M.
    Novas, M.
    Viglietta, V.
    Dawson, K. T.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 355 - 355
  • [6] Efficacy and Safety of BG-12 (Dimethyl Fumarate) in Relapsing-Remitting Multiple Sclerosis in the Phase 3 CONFIRM Study
    Hutchinson, M.
    Fox, R. J.
    Phillips, J. T.
    Miller, D. H.
    Havrdova, E.
    Kita, M.
    Yang, M.
    Zhang, R.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Dawson, K. T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 683 - 683
  • [7] Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM
    Havrdova, Eva
    Hutchinson, Michael
    Kurukulasuriya, Nuwan C.
    Raghupathi, Kartik
    Sweetser, Marianne T.
    Dawson, Katherine T.
    Gold, Ralf
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (15) : 2145 - 2156
  • [8] Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
    Gold, Ralf
    Kappos, Ludwig
    Arnold, Douglas L.
    Bar-Or, Amit
    Giovannoni, Gavin
    Selmaj, Krzysztof
    Tornatore, Carlo
    Sweetser, Marianne T.
    Yang, Minhua
    Sheikh, Sarah I.
    Dawson, Katherine T.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (12): : 1098 - 1107
  • [9] Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study
    Hutchinson, Michael
    Fox, Robert J.
    Miller, David H.
    Phillips, J. Theodore
    Kita, Mariko
    Havrdova, Eva
    O'Gorman, John
    Zhang, Ray
    Novas, Mark
    Viglietta, Vissia
    Dawson, Katherine T.
    [J]. JOURNAL OF NEUROLOGY, 2013, 260 (09) : 2286 - 2296
  • [10] Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis
    Ruggieri, Serena
    Tortorella, Carla
    Gasperini, Claudio
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 229 - 239
12345